KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) EBT (2016 - 2025)

Historic EBT for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $218.0 million.

  • Bausch Health Companies' EBT rose 113809.52% to $218.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $520.0 million, marking a year-over-year increase of 116122.45%. This contributed to the annual value of $167.0 million for FY2024, which is 14282.05% up from last year.
  • As of Q3 2025, Bausch Health Companies' EBT stood at $218.0 million, which was up 113809.52% from $140.0 million recorded in Q2 2025.
  • Bausch Health Companies' EBT's 5-year high stood at $439.0 million during Q3 2022, with a 5-year trough of -$670.0 million in Q2 2021.
  • For the 5-year period, Bausch Health Companies' EBT averaged around -$56.1 million, with its median value being -$21.0 million (2024).
  • Per our database at Business Quant, Bausch Health Companies' EBT crashed by 180000.0% in 2022 and then soared by 308571.43% in 2024.
  • Bausch Health Companies' EBT (Quarter) stood at $21.0 million in 2021, then tumbled by 1800.0% to -$357.0 million in 2022, then soared by 98.04% to -$7.0 million in 2023, then soared by 3085.71% to $209.0 million in 2024, then grew by 4.31% to $218.0 million in 2025.
  • Its last three reported values are $218.0 million in Q3 2025, $140.0 million for Q2 2025, and -$47.0 million during Q1 2025.